Company Registration No. SC153339 (Scotland)
UK Private Healthcare Limited
Unaudited accounts
for the year ended 30 June 2025
UK Private Healthcare Limited
Statement of financial position
as at 30 June 2025
Tangible assets
194,601
230,227
Investment property
248,399
275,000
Investments
807,973
720,912
Cash at bank and in hand
69,854
138,647
Creditors: amounts falling due within one year
(270,923)
(79,776)
Net current assets
1,569,211
2,125,045
Net assets
2,012,211
2,630,272
Called up share capital
350,003
350,003
Profit and loss account
1,662,208
2,280,269
Shareholders' funds
2,012,211
2,630,272
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 13 October 2025 and were signed on its behalf by
Ronald Russell
Director
Company Registration No. SC153339
UK Private Healthcare Limited
Notes to the Accounts
for the year ended 30 June 2025
UK Private Healthcare Limited is a private company, limited by shares, registered in Scotland, registration number SC153339. The registered office is 35 Albert Street, Aberdeen, AB25 1XU.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets and financial instruments at fair value.
The accounts are presented in £ sterling.
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts.
Tangible fixed assets and depreciation
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the income statement.
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant & machinery
Straight line over 7 years
Motor vehicles
Straight line over 7 years
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in the income statement.
UK Private Healthcare Limited
Notes to the Accounts
for the year ended 30 June 2025
Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell. At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in the income statement. Reversals of impairment losses are also recognised in the income statement.
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets:
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities:
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities:
Basic financial liabilities, including creditors, that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
UK Private Healthcare Limited
Notes to the Accounts
for the year ended 30 June 2025
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax:
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax:
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
Rentals payable under operating leases, including any lease incentives received, are charged to the income statement on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
UK Private Healthcare Limited
Notes to the Accounts
for the year ended 30 June 2025
4
Tangible fixed assets
Plant & machinery
Motor vehicles
Total
Cost or valuation
At cost
At cost
At 1 July 2024
51,228
267,290
318,518
At 30 June 2025
58,791
267,290
326,081
At 1 July 2024
37,749
50,542
88,291
Charge for the year
4,328
38,861
43,189
At 30 June 2025
42,077
89,403
131,480
At 30 June 2025
16,714
177,887
194,601
At 30 June 2024
13,479
216,748
230,227
Fair value at 1 July 2024
275,000
Net loss from fair value adjustments
(217,500)
The directors consider the carrying value of the investment property to be £248,399 as at 30 June 2025. The fair value of the investment property has been arrived at on the basis of valuations carried out in December 2024.
Amounts falling due within one year
Trade debtors
301,679
274,293
Accrued income and prepayments
6,807
-
Other debtors
650,000
1,067,579
7
Investments held as current assets
2025
2024
Listed investments
807,917
720,911
UK Private Healthcare Limited
Notes to the Accounts
for the year ended 30 June 2025
8
Creditors: amounts falling due within one year
2025
2024
Trade creditors
3,201
2,517
Taxes and social security
42,348
40,953
Other creditors
30,488
34,502
Loans from directors
190,898
-
Allotted, called up and fully paid:
350,003 Ordinary shares of £1 each
350,003
350,003
10
Operating lease commitments
2025
2024
At 30 June 2025 the company had the following future minimum lease payments under non-cancellable operating leases for each of the following periods:
Not later than one year
35,000
35,000
11
Average number of employees
During the year the average number of employees was 145 (2024: 165).